These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30582289)

  • 1. Corticosteroid therapy in drug-induced liver injury: Pros and cons.
    Hu PF; Xie WF
    J Dig Dis; 2019 Mar; 20(3):122-126. PubMed ID: 30582289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of corticosteroids for patients with severe drug-induced liver injury.
    Hu PF; Wang PQ; Chen H; Hu XF; Xie QP; Shi J; Lin L; Xie WF
    J Dig Dis; 2016 Sep; 17(9):618-627. PubMed ID: 27426618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis.
    Niu H; Ma J; Medina-Caliz I; Robles-Diaz M; Bonilla-Toyos E; Ghabril M; Lucena MI; Alvarez-Alvarez I; Andrade RJ
    Aliment Pharmacol Ther; 2023 Apr; 57(8):886-896. PubMed ID: 36547393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
    Weber S; Benesic A; Rotter I; Gerbes AL
    Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.
    Niu H; Atallah E; Alvarez-Alvarez I; Medina-Caliz I; Aithal GP; Arikan C; Andrade RJ; Lucena MI
    Drug Saf; 2022 Nov; 45(11):1329-1348. PubMed ID: 36006605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions and organ damage: The liver.
    Licata A
    Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
    Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
    Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: drug-induced liver injury in clinical practice.
    Björnsson E
    Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
    Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of idiosyncratic drug-induced liver injury.
    Hassan A; Fontana RJ
    Liver Int; 2019 Jan; 39(1):31-41. PubMed ID: 30003672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced liver injury: what was new in 2013?
    Chalhoub WM; Sliman KD; Arumuganathan M; Lewis JH
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):959-80. PubMed ID: 24746272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiosyncratic drug-induced liver injury: an overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed diagnosis of cholestatic drug-induced liver injury treated with corticosteroid for adrenal insufficiency secondary to miliary tuberculosis.
    Lee SY; Schneier A; Schiano T; Liu SJ; Machado ON
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3046-9. PubMed ID: 26367727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and risk factors for idiosyncratic drug-induced liver injury.
    Björnsson ES
    Semin Liver Dis; 2014 May; 34(2):115-22. PubMed ID: 24879977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.
    Fontana RJ
    Gastroenterology; 2014 Apr; 146(4):914-28. PubMed ID: 24389305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
    Björnsson HK; Björnsson ES
    Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of the incidence of herbal drug-induced liver injury in Korea.
    Oh SJ; Cho JH; Son CG
    J Ethnopharmacol; 2015 Jan; 159():253-6. PubMed ID: 25460587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.
    Björnsson HK; Gudbjornsson B; Björnsson ES
    J Hepatol; 2022 Jan; 76(1):86-92. PubMed ID: 34487751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.